Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) is an innovative, fast-growing healthcare company that discovers and develops new compounds that address unanswered medical needs and advance human health. With a strong focus on neuroscience, oncology, and cardio-renal treatments, OPDC is dedicated to improving the health and quality of human life. For more information, visit www.otsuka-us.com.
OPDC is a subsidiary of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd. The Otsuka Group employs approximately 42,000 people globally and its products are available in more than 80 countries worldwide. Otsuka welcomes you to visit its global website at https://www.otsuka.co.jp/en/.
The R&D Innovation Team provides innovation research and management support for all portfolio assets and clinical trials across OPDC with key focus on business transformation through technology integration. The team is charged with innovating and delivering solutions at the intersection of technology and therapeutics to transform OPDC clinical trial model and paving path for therapeutic solutions for patients. We believe we can define the new wave of pharma R&D business model.
The Associate Director/Director within Corporate Projects will be part of the R&D Innovation Team with a primary focus to drive innovative solutions and spearheading integration of health technologies (wearable fitness devices, clinical devices, sensors and applications) in clinical trials process. The individual will be a driving force for cross-departmental innovative solutions by leading Communities of Practice (CoP) to guide and implement pilots for business transformation. The CoPs will create and implement pilots focused on technology integration for innovate clinical trial model and paving path for therapeutic solutions for patients.
If you answered yes to these questions, we need each other in this journey. We look forward to hearing about your vision and passion around three broad areas:
Clinical, Technology, and Innovation